Québec Science recently announced the ten finalists for its 2014 Discoveries of the Year, which included three candidates from McGill with two residing in the Faculty of Medicine.
Gustavo Turecki, Chair of the Department of Psychiatry at the Faculty of Medicine and a psychiatrist at the Douglas Mental Health University Institute, discovered together with his team, that the levels of a tiny molecule, miR-1202, may provide a marker for depression and help detect individuals who are likely to respond to antidepressant treatment.
Judes Poirier, also of the Faculty of Medicine and the Douglas, and his team have discovered that a relatively frequent genetic variant actually conveys significant protection against the common form of Alzheimer’s disease and can delay the onset of the disease by as much as four years. The discovery opens new avenues for treatment against this devastating disease.
January 8, 2015